Fall IDN Summit Disclosure of Conflicts

2024 Fall IDN Summit | 8/26 - 28 | Phoenix, AZ

This activity is jointly provided by

Faculty/Planner/Reviewer/Relevant Staff Disclosure of Relevant Financial Relationships

AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, peer reviewers, and other individuals who are in a position to control the content of this activity to disclose all personal financial relationships they may have in the past 24 months with ineligible companies. An ineligible entity is any organization whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are identified and mitigated prior to initiation of the planning phase for an activity.

AXIS has mitigated and disclosed to learners all relevant financial relationships disclosed by staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.

The faculty reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:

 

Name of Faculty or Presenter

Reported Financial Relationship

Chris Chandler

Nothing to disclose

Holly Herring

Nothing to disclose

Barbara Strain

Consultant:  CosMed, Apollo Endosurgery, J2Medical, NTI Medical, AMB, Cyban, eco-pi, ETS, McMurray Medical, Fize Medical, Predictive Health, VitaGlide, Sirtex, Bannack

Jessica Gehrke

Nothing to disclose

Laura Polson

Nothing to disclose

Elizabeth Cherry

Advisor/Consultant: Takeda Oncology, Cytokinetics, Precision, Syneos, Blue Fin, Janssen

Michael O’Neal

Nothing to disclose

Angelique Vuilleumier

Nothing to disclose

Dr. Deepak Goyla

Nothing to disclose

Dr. Cameron Klug

Nothing to disclose

Janie Ott

Nothing to disclose

Ed Hisscock

Nothing to disclose

Jack Koczela

Nothing to disclose

Jason Reddish

Common Stock: Walgreens Boots Alliance (WBA)

Bonnie Kirschenbaum

Nothing to disclose

Jacqueline Thatcher

Nothing to disclose

Tim Affeldt

Nothing to disclose

Chris Little

Nothing to disclose

Rebecca Holt

Nothing to disclose

Cecile Hozouri

Nothing to disclose

Jane Torzewski

Nothing to disclose

Mike Woodman

Nothing to disclose

Sara Turnbow

Nothing to disclose

Anthony Jackson

Nothing to disclose

Sophia Humphreys

Nothing to disclose

Martha McSally

Pending

Randy Bradley

Nothing to disclose

Paul Begala

Pending

Ryan Long

Common Stock: Rocket Pharmaceuticals

Damon West

Pending

 

The planners/managers/reviewers reported the following relevant financial relationships or relationships they have with ineligible companies of any amount during the past 24 months:

 

Name of Planner/Manager/Reviewer/Staff

Reported Financial Relationship

Trey Beuttel

Nothing to disclose

Dee Morgillo. MEd., MT(ASCP), CHCP

Nothing to disclose

Holly M. Hampe, D.Sc., RN, MHA, MRM

Nothing to disclose

Contact Trey Beuttel at 859.523.5701 with any questions related to Disclosure of Conflicts

Trey Beuttel | Director, Provider Relationships and Education

P: 859.788.9699